Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$55.93 - $82.78 $854,051 - $1.26 Million
-15,270 Closed
0 $0
Q3 2020

Nov 05, 2020

SELL
$45.65 - $61.81 $24,240 - $32,821
-531 Reduced 3.36%
15,270 $863,000
Q2 2020

Aug 12, 2020

BUY
$29.15 - $61.54 $17,664 - $37,293
606 Added 3.99%
15,801 $972,000
Q1 2020

May 11, 2020

SELL
$25.01 - $42.4 $10,054 - $17,044
-402 Reduced 2.58%
15,195 $490,000
Q4 2019

Feb 05, 2020

BUY
$24.55 - $38.13 $3,240 - $5,033
132 Added 0.85%
15,597 $548,000
Q3 2019

Oct 30, 2019

BUY
$25.78 - $34.8 $398,687 - $538,182
15,465 New
15,465 $398,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.35B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.